Please wait while the formulary information is being retrieved.
OMEGA 3-6-9 (OMEGA-3 FATTY ACIDS/VITAMIN E/LINOLEIC/ALA/OLEIC/GLA/LIPASE)
1,200 mg capsule
- Dosage information is not available
40 mg-60 mg-10 unit capsule
- Dosage information is not available
1,200 mg capsule
- Dosage information is not available
40 mg-60 mg-10 unit capsule
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Appendicitis
- Disease of liver
- Duodenal obstruction
- Esophageal obstruction
- Gastrointestinal obstruction
- Inflammatory bowel disease
- Paralytic ileus
- Pyloroduodenal obstruction
Contraindicated
- Gastrointestinal obstruction
- Meconium ileus
- Schizophrenia
- Seizure disorder
Severe
Moderate
- Crohn's disease
- Fibrosing colonopathy
- Gastrointestinal tract surgery
- Gout
- Hyperuricemia
- Short bowel syndrome
OMEGA 3-6-9 (OMEGA-3 FATTY ACIDS/VITAMIN E/LINOLEIC/ALA/OLEIC/GLA/LIPASE)
- None
- Flatulence
More Frequent
Severe
Less Severe
- None
- Diarrhea
- Dysgeusia
- Dyspepsia
- Eructation
- Nausea
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abnormal hepatic function tests
- Constipation
- Pruritus of skin
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Vitamin E
Increased risk of adverse effects in neonates weight < 1 kg.
- 1 Day – 29 Days
- Increased risk of adverse effects in neonates weight < 1 kg.
Flaxseed
- Severity Level:
2
- Additional Notes: Insufficient data available; may have uterine stimulant activity
Lipase
- Severity Level:
C
- Additional Notes: Insufficient data available; consider maternal treatment benefit vs. fetal risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Borage Seed Oil
Caution warranted;Insufficient data available
Insufficient data available;Caution advised
Insuff data avail;Consider maternal treatment benefit vs possible infant risk
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Caution warranted;Insufficient data available |
Flaxseed
Caution warranted;Insufficient data available
Insufficient data available;Caution advised
Insuff data avail;Consider maternal treatment benefit vs possible infant risk
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available;Caution advised |
Lipase
Caution warranted;Insufficient data available
Insufficient data available;Caution advised
Insuff data avail;Consider maternal treatment benefit vs possible infant risk
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff data avail;Consider maternal treatment benefit vs possible infant risk |
No Known Risk
Vitamin E (systemic)
May accumulate in liver;Maternal suppl not rec unless diet insuffic in vit e
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Excreted | No adverse effect | May accumulate in liver;Maternal suppl not rec unless diet insuffic in vit e |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool